Consensus Purple Innovation, Inc.

Equities

PRPL

US74640Y1064

Real-time Estimate Cboe BZX 10:59:01 2024-05-20 am EDT 5-day change 1st Jan Change
1.465 USD -1.01% Intraday chart for Purple Innovation, Inc. +0.34% +42.23%

Evolution of the average Target Price on Purple Innovation, Inc.

Price target over the last 5 years

History of analyst recommendation changes

09c28dbeaba081880b6f57ce47fe4f63.P3w1fabi48WKCMHT2AHMdU1OY_G7TYmqR15LFHmqMZg.eBhWHJ-XofDFObmbrWaTRDgNTquKHtGcMA0sVy6ceap8GU0O97rbnMF6-Q~1d661dac31230bfafd9fb2923b2f7847
Purple Innovation Files Registration Statement for Secondary Offering MT
Roth MKM Upgrades Purple Innovation to Buy From Neutral, Raises Price Target to $2.50 From $2 MT
Craig-Hallum Adjusts Price Target on Purple Innovation to $2 From $1, Maintains Hold Rating MT
UBS Adjusts Purple Innovation Price Target to $2 From $1, Maintains Neutral Rating MT
Wedbush Adjusts Purple Innovation's Price Target to $2.25 From $1.25, Maintains Outperform Rating MT
KeyBanc Adjusts Price Target on Purple Innovation to $5 From $6, Maintains Overweight Rating MT
Oppenheimer Downgrades Purple Innovation to Perform From Outperform MT
Craig-Hallum Downgrades Purple Innovation to Hold From Buy, Cuts Price Target to $1 From $4 MT
UBS Adjusts Purple Innovation Price Target to $0.80 From $2.75, Maintains Neutral Rating MT
KeyBanc Adjusts Price Target on Purple Innovation to $6 From $8, Maintains Overweight Rating MT
KeyBanc Adjusts Purple Innovation Price Target to $6 From $8, Maintains Overweight Rating MT
Wedbush Lowers Purple Innovation's PT to $1 From $3 After Q3 Revenue, EBITDA Miss Expectations; Keeps Outperform Rating MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $3, Maintains Neutral Rating MT
Wedbush Purple Innovation's PT to $3 From $3.50 After Q2 Miss, Notes Execution Risk, Lower Industry Demand Outlook; Keeps Outperform Rating MT
UBS Adjusts Purple Innovation Price Target to $3 From $2.75, Maintains Neutral Rating MT
Wedbush Trims Purple Innovation's Price Target to $3.50 From $5, Notes Execution Risk; Keeps Outperform Rating MT
UBS Adjusts Purple Innovation Price Target to $2.75 From $6, Maintains Neutral Rating MT
Wedbush Trims Purple Innovation's Price Target $5 From $6.75, Notes 'Tough' Q4, Start to 2023; Keeps Outperform Rating MT
KeyBanc Capital Markets Adjusts Price Target on Purple Innovation to $8 From $7, Maintains Overweight Rating MT
Wedbush Adjusts Purple Innovation's Price Target to $6.75 From $5, Maintains Outperform Rating MT
UBS Adjusts Purple Innovation Price Target to $6 From $4.75, Maintains Neutral Rating MT
Keybanc Adjusts Price Target on Purple Innovation to $7.50 From $5, Maintains Overweight Rating MT
Craig-Hallum Upgrades Purple Innovation to Buy From Hold, Adjusts Price Target to $6 From $4 MT
UBS Adjusts Purple Innovation Price Target to $4.35 From $4, Maintains Neutral Rating MT
Wedbush Lifts Price Target on Purple Innovation to $5 From $3.30 After Coliseum Offer, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
1.48 USD
Average target price
2.75 USD
Spread / Average Target
+85.81%
High Price Target
5 USD
Spread / Highest target
+237.84%
Low Price Target
2 USD
Spread / Lowest Target
+35.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Purple Innovation, Inc.

Roth MKM
Craig-Hallum
UBS
Wedbush
KeyBanc Capital Markets
Oppenheimer
B. Riley
Roth Capital Partners
Truist Securities
BofA Securities
Raymond James
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. PRPL Stock
  4. Consensus Purple Innovation, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW